BNP PARIBAS FINANCIAL MARKETS - SYROS PHARMACEUTICALS INC ownership

SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 91 filers reported holding SYROS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 6.64 and the average weighting 0.1%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of SYROS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$33,317,000
+418.1%
34,608
+540.4%
0.00%
Q1 2022$6,431,000
-84.5%
5,404
-57.6%
0.00%
Q4 2021$41,578,000
-13.1%
12,754
+19.2%
0.00%
Q3 2021$47,825,000
+308.3%
10,699
+397.9%
0.00%
Q2 2021$11,712,000
-74.6%
2,149
-65.1%
0.00%
Q1 2021$46,039,000
-53.2%
6,155
-32.1%
0.00%
Q4 2020$98,290,000
+9.3%
9,059
-11.0%
0.00%
Q3 2020$89,938,000
+170.0%
10,174
+225.6%
0.00%
Q2 2020$33,312,000
-47.4%
3,125
-70.8%
0.00%
Q1 2020$63,362,000
+128.5%
10,685
+166.3%
0.00%
Q4 2019$27,730,000
-40.5%
4,013
-10.6%
0.00%
Q3 2019$46,606,000
+79.6%
4,490
+60.2%
0.00%
Q2 2019$25,947,000
-46.0%
2,802
-46.7%
0.00%
Q1 2019$48,058,000
+455.0%
5,258
+623.2%
0.00%
Q3 2018$8,659,000
+16.7%
7270.0%0.00%
Q2 2018$7,423,000
-80.7%
727
-75.5%
0.00%
Q1 2018$38,460,000
+48.7%
2,963
+11.4%
0.00%
Q4 2017$25,872,000
+33.6%
2,659
+102.1%
0.00%
Q3 2017$19,372,000
-10.1%
1,316
-1.7%
0.00%
Q2 2017$21,545,000
+1252.5%
1,339
+1239.0%
0.00%
Q1 2017$1,593,000
+9.2%
100
-16.7%
0.00%
Q4 2016$1,459,000
-36.6%
120
-27.7%
0.00%
Q3 2016$2,302,0001660.00%
Other shareholders
SYROS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
ARCH Venture Management, LLC 200,000$1,768,0008.83%
Samsara BioCapital, LLC 1,407,949$11,608,0003.24%
Flagship Pioneering Inc. 2,938,494$25,976,0000.72%
ARK Investment Management 11,212,506$99,119,0000.59%
Portolan Capital Management 450,861$3,986,0000.45%
Capital Impact Advisors, LLC 168,600$1,490,0000.44%
Nikko Asset Management Americas, Inc. 4,182,346$36,261,0000.32%
Sio Capital Management, LLC 166,780$1,474,0000.29%
Virtus ETF Advisers LLC 34,835$308,0000.16%
Artal Group S.A. 465,500$4,115,0000.10%
View complete list of SYROS PHARMACEUTICALS INC shareholders